Post Resch Tallon Group Inc.

Position in CDXS — Codexis, Inc.

CIK 2054476 PITTSFORD, NY

Position in CDXS

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$1,273,460

+$341,951 QoQ

Shares Held

563,478

-1.4% QoQ

Ownership

0.620%

of shares outstanding

% of Portfolio

2.11%

of 13F equity value

Holder Rank

of 26 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Post Resch Tallon Group Inc. holds $4,357,094 across 5 Biotechnology names. CDXS ranks #2 (29.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	50,397	$2,742,100
2	CDXS	Codexis, Inc. This page	563,478	$1,273,460
3	SNDX	Syndax Pharmaceuticals Inc	12,500	$273,250
4	AGEN	Agenus Inc	12,750	$39,015
5	CRDF	Cardiff Oncology, Inc.	22,515	$29,269

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,273,460	563,478	-1.4%	Shares	Sole	2026-07-07
2026-03-31	$931,509	571,478	+11.7%	Shares	Sole	2026-04-08
2025-12-31	$834,149	511,748	-8.6%	Shares	Sole	2026-01-09
2025-09-30	$1,366,241	559,935	+19.8%	Shares	Sole	2025-11-05
2025-06-30	$1,140,214	467,301	-0.3%	Shares	Sole	2025-07-09
2025-03-31	$1,260,499	468,587	+16.1%	Shares	Sole	2025-04-23
2024-12-31	$1,925,491	403,667	—	Shares	Sole	2025-02-04
No filing history on record for this holder in this stock.